Literature DB >> 8598667

Ischemic colitis complicating abdominal aortic aneurysm surgery in the U.S. veteran.

W E Longo1, T C Lee, M G Barnett, A M Vernava, T P Wade, G J Peterson, D L Jacobs, K S Virgo, F E Johnson.   

Abstract

Ischemic colitis (IC) is an infrequent but serious complication of abdominal aortic surgery. Prior reports have generally described small, selected populations. The aim of this paper is to evaluate characteristics of clinically diagnosed IC in a large non-referral-based population. Using national Veterans Affairs (VA) computer data sets, we identified all patients with the diagnostic codes for both prosthetic replacement of aorta for abdominal aortic aneurysm and subsequent vascular insufficiency of the intestine in the entire VA population from 1987 to 1991. Clinical information on these patients was then requested from the VA Medical Centers where they received care. Patients demographics, clinical data regarding both the aortic surgery and IC, and survival data were extracted from patient charts and computer records. Of 4957 patients who underwent surgery of the abdominal aorta for infrarenal abdominal aortic aneurysm, 58 (1.2%) also had the code for subsequent IC. In 49/58 (74%), sufficient chart-derived and computer-derived data were available for analysis. The mean age was 69 (range 57-95); all were males. Bloody diarrhea was the most frequent symptom and colonoscopy the most common means of diagnosis. Mean time to diagnosis of IC was 5.5 days after aortic surgery (range 1-21 days). Aneurysmal rupture or perioperative hypotension were present in 35/49 patients. Bowel resection with fecal diversion was required in 32/49 (65%). The overall mortality was 54% but it was 89% if bowel resection for bowel infarction was required. Only 2/12 (16%) of those who required fecal diversion and survived underwent eventual stoma closure. Among 7 patients who received second-look laparotomy for IC, additional bowel resection was required in 6. No patient had aortic graft infection diagnosed during the index hospitalization. The overall mean hospitalization duration after the diagnosis of IC was 38 days (range 1-164). IC following aortic aneurysm surgery in this national patient population is infrequently diagnosed. Emergency aneurysm operation and perioperative hypotension are common in patients who develop IC. The majority of patients diagnosed receive surgical intervention. Most patients who undergo fecal diversion retain their stomas.

Entities:  

Mesh:

Year:  1996        PMID: 8598667     DOI: 10.1006/jsre.1996.0056

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  [Colonic ischemia after open and endovascular aortic surgery : Epidemiology, Risk Factors, Diagnosis And Therapy].

Authors:  Dmitriy I Dovzhanskiy; Maani Hakimi; Moritz S Bischoff; Caro la M Wieker; Thilo Hackert; Dittmar Böckler
Journal:  Chirurg       Date:  2020-02       Impact factor: 0.955

2.  Suprarenal or supraceliac aortic clamping during repair of infrarenal abdominal aortic aneurysms.

Authors:  R A El-Sabrout; G J Reul
Journal:  Tex Heart Inst J       Date:  2001

Review 3.  Emphasis on Early Identification of Risk Factors to Curtail High Mortality Involved With Ischemic Colitis (IC) After Abdominal Aortic Aneurysm (AAA) Repair.

Authors:  Shashwat Shrivastava; Shitij Shrivastava; Supraja Naidu Avula; Vishwanath Thondamala; Chibuzor V Onuchukwu; Lubna Mohammed
Journal:  Cureus       Date:  2022-03-25

Review 4.  Risk factors for ischaemic colitis after surgery for abdominal aortic aneurysm: a systematic review and observational meta-analysis.

Authors:  Matthew J Lee; Sarah L Daniels; Thomas M Drake; Ian J Adam
Journal:  Int J Colorectal Dis       Date:  2016-06-01       Impact factor: 2.571

5.  Poor prognostic factors in patients who underwent surgery for acute non-occlusive ischemic colitis.

Authors:  Minsu Noh; Song Soo Yang; Seok Won Jung; Jae Ho Park; Yeong Cheol Im; Kyu Yeol Kim
Journal:  World J Emerg Surg       Date:  2015-03-08       Impact factor: 5.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.